Effectiveness, Implementation and Real-World Experience with Extended-Release Naltrexone (XR-NTX): A Special Issue of JSAT

J Subst Abuse Treat. 2018 Feb:85:31-33. doi: 10.1016/j.jsat.2017.11.008. Epub 2017 Nov 22.

Authors

Peter D Friedmann¹, Kelly E Dunn², Edward V Nunes³, Charles P O'Brien⁴

Affiliations

¹ Office of Research and Department of Medicine, University of Massachusetts-Baystate and Baystate Health, Springfield, MA. Electronic address: Peter.friedmannmd@baystatehealth.org.
² Johns Hopkins University School of Medicine, Baltimore, MD.
³ New York State Psychiatric Institute, Columbia University Medical Center New York, NY.
⁴ Department of Psychiatry, University of Pennsylvania, Philadelphia, PA.

PMID: 29273249
DOI: 10.1016/j.jsat.2017.11.008

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural

MeSH terms

Delayed-Action Preparations
Humans
Injections, Intramuscular / psychology
Medication Adherence / psychology
Medication Adherence / statistics & numerical data*
Naltrexone / therapeutic use*
Narcotic Antagonists / therapeutic use*
Opioid-Related Disorders / drug therapy*
United States

Substances

Delayed-Action Preparations
Narcotic Antagonists
Naltrexone

Grants and funding